United States · FDA National Drug Code directory
temozolomide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 75834-145_9db23336-458a-46a6-a676-1702497a1891
- Product NDC
- 75834-145
- Form
- CAPSULE
- Composition / generic term
- temozolomide
- Labeler
- Nivagen Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20211207
- Source listing expiry
- 20261231
Source-listed ingredients
- TEMOZOLOMIDE — 180 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CARTON in 1 CARTON (75834-145-05) / 5 CAPSULE in 1 CARTON · 75834-145-05
- 1 CARTON in 1 CARTON (75834-145-14) / 14 CAPSULE in 1 CARTON · 75834-145-14
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →